3675 MARKET STREET, PHILADELPHIA, PA
End of Material Contract, Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
Other Events
Amicus Therapeutics Special Meeting Approves Merger and Compensation Proposals
Announces Full-Year 2025 Financial Results and Corporate Updates
Earnings Release
Enters Definitive Agreement to be Acquired for $14.50 per Share in Cash, Investor Presentation
Announces Third Quarter 2025 Financial Results and Corporate Updates
Investor Presentation
FY 2024
Q3
Q2
Q1
FY 2023
Notice of Suspension of Duty to File Reports
Effectiveness Notice
Additional Proxy Materials
Definitive Merger Proxy Statement
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notification Filed by a National Security Exchange
S-8 POS
Post-Effective Amendment to Registration Statement